Results

OFS Capital Corporation

10/28/2021 | Press release | Distributed by Public on 10/28/2021 08:21

Material Definitive Agreement - Form 8-K

Document

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): October 28, 2021
OFS Capital Corporation
(Exact name of Registrant as specified in its charter)
Delaware
814-00813
46-1339639
(State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.)
10 S. Wacker Drive, Suite 2500
Chicago, Illinois 60606
(Address of principal executive offices and zip code)
(847) 734-2000
(Registrant's telephone number, including area code)
Not Applicable
(Former name or former address, if changed from last report)
Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, $0.01 par value per share OFS The Nasdaq Global Select Market
5.95% Notes due 2026 OFSSI The Nasdaq Global Select Market
6.25% Notes due 2023 OFSSG The Nasdaq Global Select Market

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
¨
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company. ¨
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨




Item 1.01 - Entry into a Material Definitive Agreement.

On October 28, 2021, OFS Capital Corporation, a Delaware corporation (the "Company"), and U.S. Bank National Association (the "Trustee"), entered into a Sixth Supplemental Indenture (the "Sixth Supplemental Indenture") to the Indenture, dated as of April 16, 2018, between the Company and the Trustee (the "Base Indenture"; and together with the Sixth Supplemental Indenture, the "Indenture"), relating to the Company's issuance of $50,000,000 aggregate principal amount of its 4.95% notes due 2028 (the "Notes").

The Notes will mature on October 31, 2028, and the Company may redeem the Notes in whole or in part at any time, or from time to time on or after October 31, 2023 at the redemption price of 100% of the aggregate principal amount thereof plus accrued and unpaid interest. The Notes bear interest at a rate of 4.95% per year payable on January 31, April 30, July 31 and October 31 of each year, commencing on January 31, 2022. The Notes are direct unsecured obligations of the Company and rank pari passu, or equal, with any future unsecured, unsecured indebtedness, senior to any of the Company's future indebtedness that expressly provides it is subordinated to the Notes, effectively subordinated to all of the Company's existing and future secured indebtedness (including indebtedness that is initially unsecured in respect of which the Company subsequently grants a security interest), to the extent of the value of the assets securing such indebtedness, including, without limitation, borrowings under the Company's senior secured revolving credit facility with Pacific Western Bank, as amended (the "PWB Credit Facility"), and structurally subordinated to all existing and future indebtedness and other obligations of any of the Company's subsidiaries.

The net proceeds the Company received from the sale of the Notes was approximately $48,137,500 based on a public offering price of $25 per Note, after deducting the underwriting discount and commissions payable by the Company and estimated offering expenses payable by the Company. The Company intends to use the net proceeds of the offering to fully or partially pay down, retire, or redeem certain of the Company's outstanding indebtedness, which may include the Company's 6.25% notes due 2023, its 5.95% notes due 2026 and/or borrowings under the Company's secured revolving credit facility with BNP Paribas (the "BNP Facility"). As of October 19, 2021, the Company had approximately $25.0 million aggregate principal amount outstanding, plus accrued interest, of 6.25% notes due 2023, which mature on September 30, 2023, and bear interest at a rate of 6.25% per annum. The Company's 6.25% notes due 2023 will be redeemed on November 1, 2021. As of October 19, 2021, the Company had approximately $54.3 million aggregate principal amount outstanding, plus accrued interest, of 5.95% Notes due 2026, which mature on October 31, 2026, and bear interest at a rate of 5.95% per annum. The Company's 5.95% notes due 2026 will be redeemed on November 22, 2021.As of October 19, 2021, the Company had $78.1 million of indebtedness outstanding under the BNP Facility, which bore interest at rates from 1.84% to 2.60% as of such date. The BNP Facility matures on June 20, 2024.

The Indenture contains certain covenants including covenants requiring the Company to comply with Section 18(a)(1)(A) as modified by Section 61(a)(2) of the Investment Company Act of 1940, as amended (the "1940 Act"), or any successor provisions, but giving effect, in either case, to any exemptive relief granted to the Company by the Securities and Exchange Commission, to comply with Section 18(a)(1)(B) as modified by Section 61(a)(2) of the 1940 Act, or any successor provisions, after giving effect to any exemptive relief granted to the Company by the SEC and subject to certain other exceptions, and to provide financial information to the holders of the Notes and the Trustee if the Company should no longer be subject to the reporting requirements under the Securities Exchange Act of 1934, as amended. These covenants are subject to important limitations and exceptions that are described in the Indenture.

The Notes were offered and sold pursuant to the Registration Statement on Form N-2 (File No. 333-255573), the preliminary prospectus filed with the Securities and Exchange Commission on October 21, 2021, the pricing term sheet filed with the Securities and Exchange Commission on October 22, 2021 and the final prospectus supplement dated October 21, 2021. The transaction closed on October 28, 2021.

The foregoing descriptions of the Sixth Supplemental Indenture and the Notes do not purport to be complete and are qualified in their entirety by reference to the full text of the Sixth Supplemental Indenture and the Notes, respectively, each filed as exhibits hereto and incorporated by reference herein.





Item 2.03 - Creation of a Direct Financial Obligation or an Obligation Under an Off-Balance Sheet Arrangement of a Registrant.

The information set forth under Item 1.01 of this Form 8-K is incorporated herein by reference.

Item 9.01 - Financial Statements and Exhibits
(a) Not applicable.

(b) Not applicable.

(c) Not applicable.

(d) Exhibits.
Exhibit No. Description
4.1
Sixth Supplemental Indenture dated of October 28, 2021 between OFS Capital Corporation and U.S. Bank National Association, as trustee.
4.2 Form of 4.95% Notes due 2028 (incorporated by reference to Exhibit 4.1 and Exhibit A therein).
5.1
Opinion of Eversheds Sutherland (US) LLP
23.1 Consent of Eversheds Sutherland (US) LLP (incorporated by reference to Exhibit 5.1)
*****










SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
OFS Capital Corporation
Date: October 28, 2021 By: /s/ Bilal Rashid
Chief Executive Officer